Journal of Shandong University (Health Sciences) ›› 2017, Vol. 55 ›› Issue (12): 31-35.doi: 10.6040/j.issn.1671-7554.0.2017.861

Previous Articles     Next Articles

Long-term prognosis of women preeclampsia and risks of incidence in their female offspring

WANG Runmei1,2, YANG Qiuhong3, ZHANG Fang1,4, MA Yuyan1   

  • Online:2017-12-20 Published:2022-09-27

Abstract: Objective To investigate the long-term prognosis of women who suffered preeclampsia and the risk of preeclampsia in their female offspring. Methods A total of 311 women with a history of preeclampsia were recruited as the observation group, while 328 women with normal delivery were enrolled as the control group. Both groups satisfied the following criteria: no history of hypertention, diabetes, renal diseases, cardiovascular and brain diseases, or other medical complications before pregnancy. The occurrence of hypertension, cardiovascular diseases and preeclampsia during pregnancy in the female offspring of these subjects were analyzed with χ2 test. Results The incidence of hypertension(23.79% vs 8.23%, P<0.001), diabetes(11.25% vs 6.71%, P=0.044), microalbuminuria(21.54% vs 6.10%, P<0.001), chronic kidney disease(10.29% vs 5.79%, P=0.036), heart failure(2.57% vs 0.61%, P=0.046), and stroke(3.22% vs 0.91%, P=0.039)were higher in the observation group than those in the control group. Long-term prognosis figures showed that the differences between the two groups were statistically significant(P<0.05). The incidence of preeclampsia in the female offspring of women with history of preeclampsia was significantly higher than those without history of preeclampsia (OR: 5.35; 95% CI: 2.20~12.97). Conclusion Preeclampsia is a risk factor for long-term cardiovascular disease. The female offspring of women with history of preeclampsia have increased risks of preeclampsia during pregnancy. For women with family history of preeclampsia, prenatal checkup should be strength- 山 东 大 学 学 报 (医 学 版)55卷12期 -王润梅,等. 子痫前期患者远期预后及其后代发病风险的评估 \=-ened and prevention measures should be taken early enough so as to improve the long-term prognosis.

Key words: Preeclampsia, Long-term prognosis, Offspring, Family history, Recurrence, Prevention and control

CLC Number: 

  • R714.25
[1] Bian Z, Shixia C, Duan T. First-trimester maternal serum levels of sFLT1, PGF and ADMA predict preeclampsia[J]. PLoS One, 2015, 10(4): 1-12.
[2] 谢幸, 苟文丽. 妇产科学[M]. 8版. 北京:人民卫生出版社, 2013: 64-71.
[3] Harmon AC, Cornelius DC, Amaral LM, et al. The role of inflammation in the pathology of preeclampsia[J]. Clin Sci(Lond), 2016, 130(6): 409-419.
[4] Bellamy L, Casas JP, Hingorani AD, et al. Preeclampsia and risk of cardiovascular disease and cancer in later life:systematic review and meta-analysis[J]. BMJ, 2007, 335(7627): 974-986.
[5] 葛均波, 徐永健. 内科学[M]. 8版. 北京:人民卫生出版社, 2013: 166, 257, 741, 524.
[6] 贾建平,陈生第. 神经病学[M]. 7版. 北京:人民卫生出版社, 2013: 170-172.
[7] Kattah AG, Asad R, Scantlebury DC, et al. Hypertension in pregnancy is a risk factor for microalbuminuria later in life[J]. J Clin Hypertens(Greenwich), 2013, 15(9): 617-623.
[8] Garovic V, August P. Preeclampsia and the future risk of hypertension: the pregnant evidence[J]. Curr Hypertens Rep, 2013, 15(2): 114-121.
[9] Ghossein-Doha C, Peeters L, van Heijster S, et al. Hypertension after preeclampsia is preceded by changes in cardiac structure and function[J]. Hypertension, 2013, 62(2): 382-390.
[10] Weissgerber TL, Mudd LM. Preeclampsia and diabetes[J]. Curr Diab Rep, 2015, 15(3): 579. doi: 10.1007/s11892-015-0579-4.
[11] Hermes W, Van K F, De GCJ. Preeclampsia and cardiovascular risk[J]. Minerva Ginecologica, 2012, 64(4):281-292.
[12] Ahmed R, Dunford J, Mehran R, et al. Preeclampsia and future cardiovascular risk among women: a review[J]. J Am Coll Cardiol, 2014, 63(18): 1815-1822.
[13] Bushnell C, Chireau M. Preeclampsia and stroke: risks during and after pregnancy[J]. Stroke Res Treat, 2011, 2011:858134. doi: 10.4061/2011/858134.
[14] McDonald SD, Han Z, Walsh MW, et al. Kidney disease after preeclampsia: a systematic review and meta-analysis[J]. Am J Kidney Dis, 2010, 55(6): 1026-1039.
[15] Asad RA, Garovic VD. Hypertension during pregnancy is associated with increased risk of chronic and end-stage kidney disease[J]. Evid Based Nurs, 2014, 17(2): 35-36.
[16] Rich-Edwards JW, Fraser A, Lawlor DA, et al. Pregnancy characteristics and womens future cardiovascular health: an underused opportunity to improve womens health?[J]. Epidemiol Rev, 2014, 36: 57-70. doi: 10.1093/epirev/mxt006. Epub 2013 Sep 11.
[17] Feig DS, Shah BR, Lipscombe LL, et al. Preeclampsia as a risk factor for diabetes: a population-based cohort study[J]. PLoS Med, 2013, 10(4):e1001425. doi: 10.1371/journal.pmed.1001425. Epub 2013 Apr 16.
[18] Skjarven R, Vatten LJ, Wilcox AJ, et al. Recurrence of preeclampsia across generations: exploring fetal and maternal genetic components in a population based cohort[J]. BMJ, 2005, 331(7521):877. Epub 2005 Sep 16.
[19] Boyd HA, Tahir H, Wohlfahrt J, et al. Associations of personal and family preeclampsia history with the risk of early-, intermediate- and late-onset preeclampsia[J]. Am J Epidemiol, 2013, 178(11):1611-1619.
[20] Roes EM, Sieben R, Raijmakers TM, et al. Severe preeclampsia is associated with a positive family history of hypertension and hypercholesterolemia[J]. Hypertens Pregnancy, 2005, 24(3):259-271.
[21] Rigó JJr, Boze T, Derzsy Z, et al. Family history of early-onset cardiovascular disorders is associated with a higher risk of severe preeclampsia[J]. Eur J Obstet Gynecol Reprod Biol, 2006, 128(1-2): 148-151.
[22] 李维, 杨孜, 王海玲, 等. 子痫前期复发影响因素的临床研究[J]. 中国实用妇科与产科杂志, 2014, 30(10):780-785. LI Wei, YANG Zi, WANG Hailing, et al. Clinical study on the factors for reoccurrence of preeclampsia[J]. Chinese Journal of Practical Gynecology and Obstetrics, 2014, 30(10): 780-785.
[23] Spaan JJ, Sep J, van Balen VL, et al. Metabolic syndrome as a risk factor for hypertension after preeclampsia[J]. Obstet gynecol, 2012, 120(2 pt 1): 311-317.
[1] SUN Lina, DU Xiaoxiao, ZHANG Hongjuan, MENG Jinlai. Human leukocyte antigen-G promotes trophoblast invasion by regulating decidual natural killer cells [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 41-45.
[2] ZHONG Lili, SHENG Ying, GUO Jianghong, YANG Shuangjian, HE Yijing. LncRNA-UCA1 effects invasion and metastasis of trophoblast cells by targeting miR-182-5p [J]. Journal of Shandong University (Health Sciences), 2022, 60(3): 76-82.
[3] ZUO Liping, JIANG Fengyang, ZHOU Binbin, FAN Jinlei, LIANG Yongfeng, DENG Zhanhao, YU Dexin. Value of preoperative multiphase MRI for predicting microvascular invasion and early recurrence of 169 hepatocellular carcinoma [J]. Journal of Shandong University (Health Sciences), 2022, 60(3): 89-95.
[4] LAN Hongtao, JIA Xu, TONG Zhoujie, ZHENG Man, HU Boang, ZHONG Ming, ZHANG Wei, WANG Zhihao. Readmission prediction of 152 non-selective adult patients with chronic heart failure [J]. Journal of Shandong University (Health Sciences), 2021, 59(4): 63-69.
[5] XIE Tonghui, CHEN Zhiqiang, CHANG Jianhua, ZHAO Danwen, XU Bowen, ZHI Xuting. Analysis of prognostic factors after radical resection of intrahepatic cholangiocarcinoma and establishment of a nomogram [J]. Journal of Shandong University (Health Sciences), 2021, 59(4): 93-99.
[6] SONG Zhenzhen, SUN Xiaoling, LI Haiou, WANG Fang, ZHANG Ran, YU Dexin. Value of MRI radiomics of glioma and peritumoral edema in evaluating tumor recurrence [J]. Journal of Shandong University (Health Sciences), 2021, 59(11): 53-60.
[7] WU Mengtao, WU Peng, YANG Yanfei, TANG Dianjun, MIAO Xiangling, LI Fandong. Application of CT venography in the diagnosis and treatment of recurrent lower extremity varicose veins [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 21-26.
[8] LI Xinrui, GENG Xingyi, WANG Weiru, ZHAO Xiaodong, LIU Lanzheng, ZHANG Xiaofei, LÜ Cuixia, CHANG Caiyun, LI Zhan, CUI Liangliang, RUAN Shiman. Consideration about cluster epidemic of 37 COVID-19 cases [J]. Journal of Shandong University (Health Sciences), 2020, 58(4): 32-40.
[9] WANG Weiru, LI Xinrui, WANG Fang, ZHAO Xiaodong, YU Qiuyan, YANG Guoliang, LI Zhan, CHANG Caiyun, ZHAO Mengjiao, LIU Xiaoxue, LI Chuanbin, SUN Zhan, GENG Xingyi. Analysis of a family cluster outbreak of coronavirus disease 2019 in Jinan City [J]. Journal of Shandong University (Health Sciences), 2020, 58(4): 54-57.
[10] Consensus Group of Diagnosis and Treatment for Coronavirus Disease 2019, Qilu Hospital of Shandong University. Diagnosis, management, prevention and control for suspected cases of coronavirus disease 2019, Qilu Hospital criteria [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 1-7.
[11] Working Team of Prevention and Control for Coronavirus Disease 2019, Qilu Hospital of Shandong University. Strategy and practice of coronavirus disease 2019 prevention and control system in Qilu Hospital of Shandong University [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 8-18.
[12] LI Shixue, SHAN Ying. Latest research advances on novel coronavirus pneumonia [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 19-25.
[13] LI Chunyu, ZHU Yuchen, QI Chang, LIU Lili, ZHANG Dandan, WANG Xu, XU Xueli, LI Xiujun. Epidemic dynamics of COVID-19 in Xinyang City, Henan Province [J]. Journal of Shandong University (Health Sciences), 2020, 58(10): 38-43.
[14] CHEN Linlin, YI Shaolei, WANG Weizong, LI Zhan, ZHANG Yong, ZHANG Yujiao,REN Manyi, XIE Xinxing, LIU Tongbao, HOU Yinglong. Risk factors of recurrent atrial fibrillation after radiofrequency catheter ablation [J]. Journal of Shandong University (Health Sciences), 2019, 57(3): 49-57.
[15] LI Fan, SHAO Jianhua, ZHAO Hongyu, DOU Chunhui, LÜ Yahui, LI Daqi. Clinical features and prognosis of adult secondary hemophagocytic syndrome: an analysis of 32 cases [J]. Journal of Shandong University (Health Sciences), 2019, 57(12): 62-67.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!